NOVNNovartisNOVN info
$116.24info0.41%24h
Global rank43
Market cap$238.92B
Change 7d-3.32%
YTD Performance13.78%
SP500 benchmarkUnderperform
P/E0
P/S5.12
Revenue$46.66B
Earnings$14.85B
Dividend yield3.0%

Novartis (NOVN) Stock Overview

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

NOVN Stock Information

Symbol
NOVN
Address
Lichtstrasse 35Basel, 4056Switzerland
Founded
-
Trading hours
-
Website
https://www.novartis.com
Country
πŸ‡¨πŸ‡­ Switzerland
Phone Number
41 61 324 1111

Novartis (NOVN) Price Chart

-
Value:-

Novartis Overview: Key Details and Summary

Stock data
2023
Change
Price
$116.24
N/A
Market Cap
$238.92B
N/A
Shares Outstanding
2.06B
-5.76%
Employees
101.70K
N/A
Shareholder Equity
46.75B
-21.33%
Valuation
2023
Change
P/S Ratio
5.12
N/A
P/B Ratio
5.11
N/A
P/FCF
20.41
N/A
POE
0.00
N/A
Dividends
2023
Change
Dividend Yield
3.04%
N/A
Dividend per share
3.5296
N/A
Dividend Payout Ratio
0.4884
N/A
Growth
2023
Change
ROIC
0.1749
N/A
CAPEX
-823.00M
N/A
Return on Equity
0.3177
N/A
Earnings
2023
Change
Revenue
$46.66B
N/A
Earnings
$14.85B
N/A
Free Cash Flow
$11.71B
N/A
Gross Margin
0.7327
N/A
Operating Margin
0.2094
N/A
Net income margin
0.3183
N/A
FCF Margin
0.2509
N/A
Financial Strength
2023
Change
Total Assets
$99.94B
N/A
Total Debt
$26.35B
N/A
Cash on Hand
$13.96B
N/A
Debt to Equity
$1.14
16.52%
Cash to Debt
0.5299
-20.55%
POE
0.0000
N/A
Current Ratio
$1.16
-10.33%
Other data
2023
Change
Buyback Yield
0.0365
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
Β© 2024 Topstocks.org